Chia Tai Enterprises International (HKSE:03839) EBIT : HK$142 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Chia Tai Enterprises International EBIT?

Chia Tai Enterprises International's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was HK$34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$142 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Chia Tai Enterprises International's annualized ROC % for the quarter that ended in Sep. 2024 was 2.73%. Chia Tai Enterprises International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 11.31%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Chia Tai Enterprises International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 15.89%.

Chia Tai Enterprises International EBIT Historical Data

The historical data trend for Chia Tai Enterprises International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chia Tai Enterprises International EBIT Chart

Chia Tai Enterprises International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

Get a 7-Day Free Trial

148.57

249.36

-13.66

38.25

142.00

Chia Tai Enterprises International Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT	Get a 7-Day Free Trial															3.87	19.44	18.13	34.05	70.68

Competitive Comparison of Chia Tai Enterprises International's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Chia Tai Enterprises International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chia Tai Enterprises International's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chia Tai Enterprises International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Chia Tai Enterprises International's EV-to-EBIT falls into.

Chia Tai Enterprises International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$142 Mil.

Chia Tai Enterprises International (HKSE:03839) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Chia Tai Enterprises International's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	84.548 * ( 1 - 25.25% )	/	( (2277.677	+	2343.914)	/ 2 )
=	63.19963	/	2310.7955
=	2.73 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2999.173	-	393.788	-	( 327.708	-	max(0, 854.32	-	1253.513	+	327.708	))
=	2277.677

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3037.36	-	425.903	-	( 267.543	-	max(0, 839.021	-	1235.107	+	267.543	))
=	2343.914

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Chia Tai Enterprises International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	136.188	/	( ( (771.823 + max(421.576, 0))	+	(797.292 + max(417.924, 0)) )	/	2 )
=	136.188	/	( ( 1193.399	+	1215.216 )	/	2 )
=	136.188	/	1204.3075
=	11.31 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(503.792	+	247.546	+	64.026)	-	(393.788	+	0	+	1.1368683772162E-13)
=	421.576

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(586.148	+	231.058	+	26.621)	-	(425.903	+	0	+	0)
=	417.924

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Chia Tai Enterprises International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	142.29	/	895.449
	=	15.89 %

Chia Tai Enterprises International EBIT Related Terms

Thank you for viewing the detailed overview of Chia Tai Enterprises International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Chia Tai Enterprises International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chia Tai Enterprises International Ltd (HKSE:03839) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

16 Harcourt Road, 21st Floor, Far East Finance Centre, Hong Kong, HKG

Website

http://www.ctei.com.hk

Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China which generates key revenue, Asia Pacific (excluding mainland China), Americas, Europe, and Others.

Chia Tai Enterprises International Headlines

No Headlines